Impact of statin treatment on cardiovascular events in patients with retinal vein occlusion: a nested case-control study in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Retinal vein occlusion (RVO) is associated with an increased risk of future cardiovascular events. Statin therapy is a key cornerstone in prevention for patients at high cardiovascular risk. However, little is known about the role of statin therapy for patients with RVO. This study evaluated whether statin treatment in patients with RVO was associated with a lower risk of cardiovascular events. METHODS: A population-based, nested case-control study was conducted with a cohort of newly diagnosed RVO patients without prior cardiovascular disease between 2008 and 2020 using a nationwide health claims database in Korea. From this cohort of RVO patients, we identified cases of cardiovascular events (stroke or myocardial infarction) after RVO and matched controls based on sex, age, insurance type, antiplatelet use, and underlying comorbidities using 1:2 incidence density sampling. RESULTS: Using a cohort of 142,759 patients with newly diagnosed RVO, we selected 6,810 cases and 13,620 matched controls. A significantly lower risk of cardiovascular events (adjusted odds ratio, 0.604; 95% confidence interval, 0.557 to 0.655) was observed in RVO patients with statin treatment than in those without statin treatment. Statin treatment was associated with a reduced risk for both stroke and myocardial infarction after RVO. Longer statin treatment after RVO was associated with a lower risk for cardiovascular events. CONCLUSIONS: Statin treatment was associated with a lower risk for future cardiovascular events in patients with newly diagnosed RVO. Further studies are warranted to clarify the potential cardiovascular preventive role of statins in patients with RVO.
Abstract
OBJECTIVES: Retinal vein occlusion (RVO) is associated with an increased risk of future cardiovascular events. Statin therapy is a key cornerstone in prevention for patients at high cardiovascular risk. However, little is known about the role of statin therapy for patients with RVO. This study evaluated whether statin treatment in patients with RVO was associated with a lower risk of cardiovascular events. METHODS: A population-based, nested case-control study was conducted with a cohort of newly diagnosed RVO patients without prior cardiovascular disease between 2008 and 2020 using a nationwide health claims database in Korea. From this cohort of RVO patients, we identified cases of cardiovascular events (stroke or myocardial infarction) after RVO and matched controls based on sex, age, insurance type, antiplatelet use, and underlying comorbidities using 1:2 incidence density sampling. RESULTS: Using a cohort of 142,759 patients with newly diagnosed RVO, we selected 6,810 cases and 13,620 matched controls. A significantly lower risk of cardiovascular events (adjusted odds ratio, 0.604; 95% confidence interval, 0.557 to 0.655) was observed in RVO patients with statin treatment than in those without statin treatment. Statin treatment was associated with a reduced risk for both stroke and myocardial infarction after RVO. Longer statin treatment after RVO was associated with a lower risk for cardiovascular events. CONCLUSIONS: Statin treatment was associated with a lower risk for future cardiovascular events in patients with newly diagnosed RVO. Further studies are warranted to clarify the potential cardiovascular preventive role of statins in patients with RVO.
참고문헌 (49)
- McIntosh RL, "Natural history of central retinal vein occlusion : an evidence-based systematic review", Ophthalmology, 117, pp.1113~1123.e15 (2010)
- Rogers SL, "Natural history of branch retinal vein occlusion : an evidence-based systematic review", Ophthalmology, 117, pp.1094~1101.e5 (2010)
- Scott IU, "Retinal vascular occlusions", Lancet, 396, pp.1927~1940 (2020)
- Hayreh SS, "Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics", Am J Ophthalmol, 117, pp.429~441 (1994)
- Park SJ, "Nationwide incidence of clinically diagnosed retinal vein occlusion in Korea, 2008 through 2011 : preponderance of women and the impact of aging", Ophthalmology, 121, pp.1274~1280 (2014)
- Park SJ, "Risk of stroke in retinal vein occlusion", Neurology, 85, pp.1578~1584 (2015)
- Rim TH, "Retinal vein occlusion and the risk of stroke development : a 9-year nationwide population-based study", Ophthalmology, 122, pp.1187~1194 (2015)
- Chen YY, "Association between retinal vein occlusion and an increased risk of acute myocardial infarction : a nationwide population-based follow-up study", PLoS One, 12, pp.e0184016~ (2017)
- Rim TH, "Retinal vein occlusion and the risk of acute myocardial infarction development : a 12-year nationwide cohort study", Sci Rep, 6, pp.22351~ (2016)
- Bakhoum CY, "Retinal vein occlusion is associated with stroke independent of underlying cardiovascular disease", Eye(Lond), 37, pp.764~767 (2023)
- Zhong C, "Retinal vein occlusion and risk of cerebrovascular disease and myocardial infarction : a meta-analysis of cohort studies", Atherosclerosis, 247, pp.170~176 (2016)
- Klein R, "The epidemiology of retinal vein occlusion : the Beaver Dam Eye Study", Trans Am Ophthalmol Soc, 98, pp.133~143 (2000)
- Bertelsen M, "Comorbidity in patients with branch retinal vein occlusion : case-control study", BMJ, 345, pp.e7885~ (2012)
- Arnett DK, "2019 ACC", AHA guideline on the primary prevention of cardiovascular disease : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2019, 74[DOI]
- Visseren FL, "2021 ESC Guidelines on cardiovascular disease prevention in clinical practice", Eur Heart J, 42, pp.3227~3337 (2021)
- 김선예, "The risk of stroke according to statin medication compliance in older people with chronic periodontitis: an analysis using the Korea National Health Insurance Service-Senior Cohort Database", Epidemiology and Health, 44, pp.1~8 (2022), 한국역학회[DOI]
- Mac Grory B, "Management of central retinal artery occlusion : a scientific statement from the American Heart Association", Stroke, 52, pp.e282~e294 (2021)
- Kim L, "A guide for the utilization of Health Insurance Review and Assessment Service national patient samples", Epidemiol Health, 36, pp.2014008~ (2014)
- Kim Rock Bum, "Epidemiology of myocardial infarction in Korea: hospitalization incidence, prevalence, and mortality", Epidemiology and Health, 44, pp.1~11 (2022), 한국역학회[DOI]
- Christiansen CB, "Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion : a nationwide cohort study", BMC Cardiovasc Disord, 18, pp.91~ (2018)
- Kim J, "Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea", Hypertension, 72, pp.391~398 (2018)
- Si-Un Lee, "Trends in the Incidence and Treatment of Cerebrovascular Diseases in Korea : Part I. Intracranial Aneurysm, Intracerebral Hemorrhage, and Arteriovenous Malformation", 대한신경외과학회지, 63(1), pp.56~68 (2020), 대한신경외과학회
- Jee SH, "A coronary heart disease prediction model : the Korean Heart Study", BMJ Open, 4, pp.e005025~ (2014)
- 박태환, "Validation of Stroke and Trombolytic Terapy in Korean National Health Insurance Claim Data", Journal of Clinical Neurology, 12(1), pp.42~48 (2016), 대한신경과학회[DOI]
- Park J, "Validation of diagnostic codes of major clinical outcomes in a National Health Insurance database", Int J Arrhythm, 20, pp.5~ (2019)
- Richardson DB, "An incidence density sampling program for nested case-control analyses", Occup Environ Med, 61, pp.e59~ (2004)
- Cho IS, "Statistical methods for elimination of guarantee-time bias in cohort studies : a simulation study", BMC Med Res Methodol, 17, pp.126~ (2017)
- Kim J, "Association between the risk for cardiovascular events and antiviral treatment for herpes zoster", Clin Infect Dis, 73, pp.758~764 (2021)
- Han M, "Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea", Sci Rep, 12, pp.5545~ (2022)
- VanderWeele TJ, "Sensitivity analysis in observational research : introducing the E-value", Ann Intern Med, 167, pp.268~274 (2017)
- Shavadia JS, "Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease", Am Heart J, 231, pp.36~44 (2021)
- Simon R, "A non-parametric graphical representation of the relationship between survival and the occurrence of an event : application to responder versus non-responder bias", Stat Med, 3, pp.35~44 (1984)
- Lazo-Langner A, "Low molecular weight heparin for the treatment of retinal vein occlusion : a systematic review and meta-analysis of randomized trials", Haematologica, 95, pp.1587~1593 (2010)
- Marcucci R, "Retinal vein occlusions : a review for the internist", Intern Emerg Med, 6, pp.307~314 (2011)
- Matei VM, "Poor outcomes despite aspirin or statin use in high-risk patients with retinal vein occlusion", Graefes Arch Clin Exp Ophthalmol, 255, pp.761~766 (2017)
- Yau JW, "Retinal vein occlusion : an approach to diagnosis, systemic risk factors and management", Intern Med J, 38, pp.904~910 (2008)
- Rehak M, "Retinal vein thrombosis : pathogenesis and management", J Thromb Haemost, 8, pp.1886~1894 (2010)
- Cellai AP, "A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion", Atherosclerosis, 224, pp.97~101 (2012)
- Shahid H, "The management of retinal vein occlusion: is interventional ophthalmology the way forward?", Br J Ophthalmol, 90, pp.627~639 (2006)
- O’Mahoney PR, "Retinal vein occlusion and traditional risk factors for atherosclerosis", Arch Ophthalmol, 126, pp.692~699 (2008)
- Green WR, "Central retinal vein occlusion : a prospective histopathologic study of 29 eyes in 28 cases", Trans Am Ophthalmol Soc, 79, pp.371~422 (1981)
- Georgios Tsivgoulis, "Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke", 대한뇌졸중영문학회지, 20(2), pp.145~166 (2018), 대한뇌졸중학회
- Jong S. Kim, "Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines", 대한뇌졸중영문학회지, 23(2), pp.149~161 (2021), 대한뇌졸중학회[DOI]
- Sofi F, "High lipoprotein(a)levels are associated with an increased risk of retinal vein occlusion", Atherosclerosis, 210, pp.278~281 (2010)
- Al-Janabi A, "Statins in retinal disease", Eye(Lond), 32, pp.981~991 (2018)
- Hadjiphilippou S, "Cholesterol-lowering agents", Circ Res, 124, pp.354~363 (2019)
- Undas A, "Statins and blood coagulation", Arterioscler Thromb Vasc Biol, 25, pp.287~294 (2005)
- Liao JK, "Pleiotropic effects of statins", Annu Rev Pharmacol Toxicol, 45, pp.89~118 (2005)
- Biere-Rafi S, "Statin treatment and the risk of recurrent pulmonary embolism", Eur Heart J, 34, pp.1800~1806 (2013)